Pro Medicus Limited Stock OTC Markets
Stocks
PMDIY
US74276V1035
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
22:15:21 22/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 23.35 USD | -1.16% |
|
-.--% | -29.69% |
| Market Cap | 16.34B 11.35B 10.09B 9.42B 8.58B 16.19B 1,092B 114B 44.16B 558B 42.63B 41.71B 1,791B | P/E 2027 * |
87.2x | P/E 2028 * | 68.3x |
|---|---|---|---|---|---|
| Enterprise Value | 16.04B 11.15B 9.91B 9.25B 8.43B 15.9B 1,072B 112B 43.36B 548B 41.87B 40.96B 1,759B | EV / Sales 2027 * |
47.4x | EV / Sales 2028 * | 37.9x |
| Free-Float |
51.04% | Yield 2027 * |
0.6% | Yield 2028 * | 0.73% |
Last Transcript: Pro Medicus Limited
| 1 day | -1.16% | ||
| 1 month | -6.22% | ||
| 3 months | -22.17% | ||
| 6 months | +38.66% | ||
| Current year | -29.69% |
| 1 month | 20.95 | 24.88 | |
| Current year | 14.2 | 30 | |
| 1 year | 14.2 | 39.54 | |
| 3 years | 13.25 | 45.75 | |
| 5 years | 13.25 | 45.75 | |
| 10 years | 13.25 | 45.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Hupert
CEO | Chief Executive Officer | - | 01/10/2010 |
Anthony Hall
CTO | Chief Tech/Sci/R&D Officer | - | - |
Danny English
DFI | Director of Finance/CFO | - | 16/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Hall
BRD | Director/Board Member | - | 01/01/1983 |
Peter Kempen
CHM | Chairman | 75 | 01/08/2010 |
Anthony Glenning
BRD | Director/Board Member | - | 01/05/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.16% | -.--% | - | - | 11.35B | ||
| +0.35% | -2.99% | +20.52% | +30.32% | 242B | ||
| +1.09% | -4.65% | -0.43% | -0.93% | 150B | ||
| -2.32% | -3.27% | -13.35% | +35.02% | 138B | ||
| -1.46% | -3.01% | -56.23% | -17.36% | 61.74B | ||
| -0.05% | -1.32% | +10.48% | +19.48% | 49.08B | ||
| -1.62% | -3.72% | -22.95% | -22.02% | 47.43B | ||
| +0.66% | -2.90% | +18.46% | +50.25% | 47.3B | ||
| -3.05% | -2.62% | -7.75% | +36.34% | 44.25B | ||
| -0.08% | -1.92% | +29.48% | +58.80% | 41.78B | ||
| Average | -0.76% | -2.50% | -2.42% | +21.10% | 91.4B | |
| Weighted average by Cap. | -0.43% | -2.98% | +0.94% | +21.07% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 339M 235M 209M 195M 178M 336M 22.63B 2.36B 915M 11.57B 884M 865M 37.12B | 420M 292M 259M 242M 221M 416M 28.05B 2.93B 1.13B 14.34B 1.1B 1.07B 46.03B |
| Net income | 186M 129M 115M 107M 97.53M 184M 12.4B 1.29B 502M 6.34B 484M 474M 20.35B | 239M 166M 147M 138M 125M 237M 15.96B 1.67B 645M 8.16B 623M 610M 26.18B |
| Net Debt | -293M -204M -181M -169M -154M -291M -19.59B -2.05B -793M -10.02B -765M -749M -32.15B | -405M -282M -250M -233M -213M -401M -27.07B -2.83B -1.09B -13.84B -1.06B -1.03B -44.41B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | $0.000000 | - | 91 |
| 01/10/26 | $0.000000 | - | 123 |
| 30/09/26 | $0.000000 | - | 21 |
| 29/09/26 | $0.000000 | - | 18 |
| 28/09/26 | $0.000000 | - | 47 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PME Stock
- PMDIY Stock
Select your edition
All financial news and data tailored to specific country editions
















